These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
107 related items for PubMed ID: 1559752
1. Lack of retinal toxicity of the anticytomegalovirus drug (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl) cytosine. Dolnak DR, Munguia D, Wiley CA, De Clercq E, Bergeron-Lynn GL, Boscher C, Connor JD, Sherwood C, Capparelli E, Armani R. Invest Ophthalmol Vis Sci; 1992 Apr; 33(5):1557-63. PubMed ID: 1559752 [Abstract] [Full Text] [Related]
2. Effect of partial retinal destruction and gliosis on the intravitreal pharmacokinetics of HPMPC. Kim JW, el-Haig W, Capparelli EV, Besen G, Connor JD, Freeman WR. Retina; 1995 Apr; 15(6):513-7. PubMed ID: 8747447 [Abstract] [Full Text] [Related]
3. Evaluation of retinal toxicity and liposome encapsulation of the anti-CMV drug 2'-nor-cyclic GMP. Shakiba S, Assil KK, Listhaus AD, Munguia D, Flores-Aguilar M, Vuong C, Wiley CA, Tolman RL, Karkas JD, Bergeron-Lynn G. Invest Ophthalmol Vis Sci; 1993 Sep; 34(10):2903-10. PubMed ID: 8395482 [Abstract] [Full Text] [Related]
4. Distribution and metabolism of intravitreal cidofovir and cyclic HPMPC in rabbits. Cundy KC, Lynch G, Shaw JP, Hitchcock MJ, Lee WA. Curr Eye Res; 1996 May; 15(5):569-76. PubMed ID: 8670758 [Abstract] [Full Text] [Related]
8. Toxicologic and pharmacokinetic analysis of intravitreal injections of foscarnet, either alone or in combination with ganciclovir. Berthe P, Baudouin C, Garraffo R, Hofmann P, Taburet AM, Lapalus P. Invest Ophthalmol Vis Sci; 1994 Mar; 35(3):1038-45. PubMed ID: 8125715 [Abstract] [Full Text] [Related]
9. Influence of intravitreal injections of HPMPC and related nucleoside analogues on intraocular pressure in guinea pig eyes. Banker AS, De Clercq E, Taskintuna I, Keefe KS, Bergeron-Lynn G, Freeman WR. Invest Ophthalmol Vis Sci; 1998 Jun; 39(7):1233-42. PubMed ID: 9620084 [Abstract] [Full Text] [Related]
10. Therapeutic potential of Cidofovir (HPMPC, Vistide) for the treatment of DNA virus (i.e. herpes-, papova-, pox- and adenovirus) infections. De Clercq E. Verh K Acad Geneeskd Belg; 1996 Jun; 58(1):19-47; discussion 47-9. PubMed ID: 8701600 [Abstract] [Full Text] [Related]
11. New inhibitors of cytomegalovirus replication: in vitro evaluation, mechanism of action, and in vivo activity. Neyts J, De Clercq E. Verh K Acad Geneeskd Belg; 1994 Jun; 56(6):561-92. PubMed ID: 7892749 [Abstract] [Full Text] [Related]
12. Activity of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl) cytosine against human cytomegalovirus when administered as single-bolus dose and continuous infusion in in vitro cell culture perfusion system. Moore MR, Hamzeh FM, Lee FE, Lietman PS. Antimicrob Agents Chemother; 1994 Oct; 38(10):2404-8. PubMed ID: 7840578 [Abstract] [Full Text] [Related]
14. Liposome-encapsulated (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine for long-acting therapy of viral retinitis. Kuppermann BD, Assil KK, Vuong C, Besen G, Wiley CA, De Clercq E, Bergeron-Lynn G, Connor JD, Pursley M, Munguia D, Freeman WR. J Infect Dis; 1996 Jan; 173(1):18-23. PubMed ID: 8537656 [Abstract] [Full Text] [Related]
15. Selective inhibition of human cytomegalovirus DNA synthesis by (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine [(S)-HPMPC] and 9-(1,3-dihydroxy-2-propoxymethyl)guanine (DHPG). Neyts J, Snoeck R, Schols D, Balzarini J, De Clercq E. Virology; 1990 Nov; 179(1):41-50. PubMed ID: 2171213 [Abstract] [Full Text] [Related]
16. Characterization of a novel intraocular drug-delivery system using crystalline lipid antiviral prodrugs of ganciclovir and cyclic cidofovir. Cheng L, Hostetler KY, Lee J, Koh HJ, Beadle JR, Bessho K, Toyoguchi M, Aldern K, Bovet JM, Freeman WR. Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):4138-44. PubMed ID: 15505067 [Abstract] [Full Text] [Related]
17. Intraocular properties of an alkoxyalkyl derivative of cyclic 9-(S)-(3-hydroxyl-2-phosphonomehoxypropyl) adenine, an intravitreally injectable anti-HCMV drug in rabbit and guinea pig. Tammewar AM, Cheng L, Hostetler KY, Falkenstein I, Beadle JR, Barron EC, Kozak I, Freeman WR. J Ocul Pharmacol Ther; 2007 Oct; 23(5):433-44. PubMed ID: 17900229 [Abstract] [Full Text] [Related]
18. Anterior nongranulomatous uveitis after intravitreal HPMPC (cidofovir) for the treatment of cytomegalovirus retinitis. Analysis and prevention. Chavez-de la Paz E, Arevalo JF, Kirsch LS, Munguia D, Rahhal FM, De Clercq E, Freeman WR. Ophthalmology; 1997 Mar; 104(3):539-44. PubMed ID: 9082286 [Abstract] [Full Text] [Related]
19. Pharmacokinetics, bioavailability, metabolism, and tissue distribution of cidofovir (HPMPC) and cyclic HPMPC in rats. Cundy KC, Bidgood AM, Lynch G, Shaw JP, Griffin L, Lee WA. Drug Metab Dispos; 1996 Jul; 24(7):745-52. PubMed ID: 8818571 [Abstract] [Full Text] [Related]
20. Intraocular toxicity and pharmacokinetics of candesartan in a rabbit model. Lee JE, Lim DW, Park HJ, Shin JH, Lee SM, Oum BS. Invest Ophthalmol Vis Sci; 2011 May 02; 52(6):2924-9. PubMed ID: 21228384 [Abstract] [Full Text] [Related] Page: [Next] [New Search]